Proteolytic and non-proteolytic migration of tumour cells and leucocytes
The DOI matches its Crossref record.
Abstract
The migration of different cell types, such as leucocytes and tumour cells, involves cellular strategies to overcome the physical resistance of three-dimensional tissue networks, including proteolytic degradation of extracellular matrix (ECM) components. High-resolution live-cell imaging techniques have recently provided structural and biochemical insight into the differential use of matrix-degrading enzymes in the migration processes of different cell types within the three-dimensional ECM. Proteolytic migration is achieved by slow-moving cells, such as fibroblasts and mesenchymally moving tumour cells, by engaging matrix metalloproteinases, cathepsins and serine proteases at the cell surface in a focalized manner ('pericellular proteolysis'), while adhesion and migratory traction are provided by integrins. Pericellular breakdown of ECM components generates localized matrix defects and remodelling along migration tracks. In contrast with tumour cells, constitutive non-proteolytic migration is used by rapidly moving T lymphocytes. This migration type does not generate proteolytic matrix remodelling, but rather depends on shape change to allow cells to glide and squeeze through gaps and trails present in connective tissues. In addition, constitutive proteolytic migration can be converted into non-proteolytic movement by protease inhibitors. After the simultaneous inhibition of matrix metalloproteinases, serine/threonine proteases and cysteine proteases in tumour cells undergoing proteolysis-dependent movement, a fundamental adaptation towards amoeboid movement is able to sustain non-proteolytic migration in these tumour cells (the mesenchymal-amoeboid transition). Instead of using proteases for matrix degradation, the tumour cells use leucoyte-like strategies of shape change and squeezing through matrix gaps along tissue scaffolds. The diversity of protease function in cell migration by different cell types highlights response diversity and molecular adaptation of cell migration upon pharmacotherapeutic protease inhibitor treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Tumour-cell invasion and migration: diversity and escape mechanisms
Friedl, P., & Wolf, K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1075 · Cited by 3,222
Self-citationCollective cell migration in morphogenesis, regeneration and cancer
Friedl, P., & Gilmour, D. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2720 · Cited by 2,712
Self-citationConcepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Plasticity of cell migration: a multiscale tuning model
Friedl, P., & Wolf, K. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200909003 · Cited by 1,355
Self-citationAnoikis molecular pathways and its role in cancer progression
Paoli, P., Giannoni, E., & Chiarugi, P. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.026 · Cited by 1,160
“hering cells, among which hematopoietic stem cells and leukocytes [70].”
BackgroundActin and Actin-Binding Proteins
Pollard, T. D. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018226 · Cited by 912
The impact of the extracellular matrix on inflammation
Sorokin, L. (2010) · Nature Reviews Immunology · doi:10.1038/nri2852 · Cited by 912
Prespecification and plasticity: shifting mechanisms of cell migration
Friedl, P. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.11.001 · Cited by 667
Self-citationCollagen-based cell migration models in vitro and in vivo
Wolf, K., Alexander, S., Schacht, V., Coussens, L. M., von Andrian, U. H., van Rheenen, J., Deryugina, E., & Friedl, P. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.08.005 · Cited by 637
Self-citationInterstitial leukocyte migration and immune function
Friedl, P., & Weigelin, B. (2008) · Nature Immunology · doi:10.1038/ni.f.212 · Cited by 587
Self-citationThe actin cytoskeleton in cancer cell motility
Olson, M. F., & Sahai, E. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9174-2 · Cited by 572
Anoikis: A necessary death program for anchorage-dependent cells
Chiarugi, P., & Giannoni, E. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.023 · Cited by 494
Actin Dynamics at the Leading Edge: From Simple Machinery to Complex Networks
Insall, R. H., & Machesky, L. M. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.08.012 · Cited by 428
ROCK and JAK1 Signaling Cooperate to Control Actomyosin Contractility in Tumor Cells and Stroma
Sanz-Moreno, V., Gaggioli, C., Yeo, M., Albrengues, J., Wallberg, F., Viros, A., Hooper, S., Mitter, R., Féral, C. C., Cook, M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.018 · Cited by 409
Extracellular matrix determinants of proteolytic and non-proteolytic cell migration
Wolf, K., & Friedl, P. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.006 · Cited by 336
Self-citationMader, C. C., Oser, M., Magalhaes, M. A. O., Bravo-Cordero, J. J., Condeelis, J., Koleske, A. J., & Gil-Henn, H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1432 · Cited by 294
Proteolytic interstitial cell migration: a five-step process
Friedl, P., & Wolf, K. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9174-3 · Cited by 288
Self-citationPDK1 Regulates Cancer Cell Motility by Antagonising Inhibition of ROCK1 by RhoE
Pinner, S., & Sahai, E. (2008) · Nature Cell Biology · doi:10.1038/ncb1675 · Cited by 267
The septin cytoskeleton facilitates membrane retraction during motility and blebbing
Gilden, J. K., Peck, S., M. Chen, Y.-C., & Krummel, M. F. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201105127 · Cited by 113
“As tumor cells have been shown to adopt blebbing motility under conditions that are unfavorable to their more common fibroblast-like motility (Friedl and Wolf, 2003; Sahai and Marshall, 2003), it may be informative to investigate whether SEPT9 contributes to metastasis by modulating when and where blebs and protrusion…”
Metadata
- Authors
- Friedl, P., & Wolf, K.
- Venue
- Biochemical Society Symposia
- Publisher
- Portland Press Ltd.
- Published
- 2003-09-01
- Volume
- 70
- Issue
- 70
- Pages
- 277-285
- ISSN
- 0067-8694 (ISSN-L)
- 1744-1439
- OpenAlex
- W1808710027
- Cited by
- 148
- References
- 0
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.